[1] Nathan C,Xie QW.Nitric oxide synthases:roles,tolls,and controls[J].Cell,1994,78(6):915-918.
[2] 吕福云,杜闻博,佟淑平,等.呼出气一氧化氮检测及其临床意义研究进展[J].实用心脑肺血管病杂志,2014,22(12):1-4.
[3] American Thoracic Society,European Respiratory Society.ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide,2005[J].Am J Respir Crit Care Med,2005,171(8):912-930.
[4] Reddel HK,Taylor DR,Bateman ED,et a1.An official American Thoracic Society/European Respiratory Society statement:asthma control and exacerbations:standardizing endpoints for clinical asthma trials and clinical practice[J].Am J Respir Crit Care Med,2009,180(1):59-99.
[5] Dweik RA,Boggs PB,Erzurum SC,et al.An official ATS clinical practice guideline:interpretation of exhaled nitric oxide levels(FeNO)for clinical applications[J]. Am J Respir Crit Care Med, 2011,184(5):602-615.
[6] Bateman ED,Hurd SS,Barnes PJ,et al.Global strategy for asthma management and prevention:GINA executive summary[J].Eur Respir J,2008,31(1):143-178.
[7] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案)[J].中华结核和呼吸杂志,2008,31(3):177-185.
[8] 平淼文,王彦,曹洁,等.吸烟对慢性气道炎症患者FeNO表达的影响[J].天津医药,2016,44(1):29-32.
[9] Ricciardolo FL,Sorbello V,Ciprandi G.A pathophysiological approach for FeNO:A biomarker for asthma[J].Allergol Immunopathol(Madr),2015,43(6):609-616.
[10] Malerba M,Radaeli A,Olivini A,et al.Exhaled nitric oxide as a biomarker in COPD and related comorbidities[J].Biomed Res Int,2014,doi:10.1155/2014/271918.
[11] GOLD,GINA.Diagnosis of diseases of Chronic Airflow Limitation:Asthma,COPD and Asthma-COPD overlap syndrome(ACOS),Updated 2015[EB/OL].A Joint Project of GINA and GOLD,2015.
[12] Miravitlles M,Alcázar B,Alvarez FJ,et al.What pulmonologists think about the asthma-COPD overlap syndrome[J].Int J Chron Obstrct Pulmon Dis,2015,10:1321-1330.
[13] Ding B,Enstone A.Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights[J].Expert Rev Respir Med,2016,10(3): 363-371.
[14] Donohue JF,Herje N,Crater G,et al.Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels:a pilot study[J].Int J Chron Obstruct Pulmon Dis,2014,9:745-751.
[15] 符丹丹,欧阳瑶.FENO在COPD患者急性加重期及缓解期中相关关系的研究[J].医学信息,2014,27(3下):196.
Kharitonov SA,Bames PJ.Clinical aspects of exhaled nitric oxide[J].Eur Respir J,2000,16(4):781-792.
[16] 史菲. 呼出气一氧化氮对哮喘-COPD重叠综合征的诊疗价值[J].中华急诊医学杂志,2015,24(6):634-638.
[17] Tamada T,Sugiura H,Takahashi T,et al.Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations[J].Int J Chron Obstruct Pulmon Dis,2015,10:2169-2176.
[18] Lex C,Ferreira F,Zacharasiewicz A,et al.Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests[J].Am J Respir Crit Care Med,2006,174(12):1286-1291.
[19] Zietkowski Z,Lukaszyk A,Tomasiak MM,et al.Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naive asthma patients[J]. J Investig Allergol Clin Immunol, 2006,16(4):239-246.
[20] 张雅军. 呼出气一氧化氮测定与哮喘患者血EOS、IgE及FEV1/pred相关性分析[J].中国实用医药,2014,9(19):66-67.
[21] 李娜嘉,林江涛.呼出气一氧化氮检测在呼吸道疾病诊治中的应用进展[J].中华医学杂志,2014,94(42):3354-3356.
[22] 张树荣,安忠碧,张彦,等.呼出气一氧化氮在老年哮喘-慢阻肺重叠综合征患者中的测定[J].临床肺科杂志,2016,21(2):217-219.
[23] Fabbri LM,Romagnoli M,Corbetta L,et al.Differences in airway inflammation in patients with airway obstruction due to asthma or chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2003,167(3):418-424.
[24] Di Lorenzo G,Mansueto P,Ditta V,et al.Similarity and differences in elderly patients with fixed airflow obstruction by asthma and by chronic obstructive pulmonary disease[J].Respir Med,2008,102(2):232-238.
[25] Miravitlles M,Soler-Catalua JJ,Calle M,et al.A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC)[J].Prim Care Respir J,2013,22(1):117-121.
[26] 孙永昌. 慢阻肺基于临床表型的分级和治疗:西班牙慢阻肺指南解读[J].中华结核和呼吸杂志,2014,37(9):652-654.
[27] Kitaguchi Y,Komatsu Y,Fujimoto K,et al.Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma[J]. Int J Chron Obstruct Pulmon Dis,2012,7:283-289.
[28] Kim MA,Noh CS,Chang YJ,et al.Asthma and COPD overlap syndrome is associated with increased risk of hospitalisation[J].Int J Tuberc Lung Dis,2015,19(7):864-869.
[29] Akamatsu K,Matsunaga K,Sugiura H,et al.Improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease:what is the specific marker?[J].Front Pharmacol,2011,2:36.
[30] 许菡苡. 哮喘-慢性阻塞性肺疾病重叠综合征(ACOS)的临床研究[D].北京:中国人民解放军医学院,2015. |
